Tyrosine phosphorylation-dependent signalling is coordinated by the opposing actions of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). There is a growing list of adaptor proteins that interact with PTPs and facilitate the dephosphorylation of substrates. The extent to which any given adaptor confers selectivity for any given substrate in vivo remains unclear. Here we have taken advantage of Drosophila melanogaster as a model organism to explore the influence of the SH3/SH2 adaptor protein Dock on the abilities of the membrane (PTP61Fm)-and nuclear (PTP61Fn)-targeted variants of PTP61F (the Drosophila othologue of the mammalian enzymes PTP1B and TCPTP respectively) to repress PTK signalling pathways in vivo. PTP61Fn effectively repressed the eye overgrowth associated with activation of the epidermal growth factor receptor (EGFR), PTK, or the expression of the platelet-derived growth factor/vascular endothelial growth factor receptor (PVR) or insulin receptor (InR) PTKs. PTP61Fn repressed EGFR and PVR-induced mitogen-activated protein kinase signalling and attenuated PVR-induced STAT92E signalling. By contrast, PTP61Fm effectively repressed EGFR-and PVR-, but not InR-induced tissue overgrowth. Importantly, coexpression of Dock with PTP61F allowed for the efficient repression of the InR-induced eye overgrowth, but did not enhance the PTP61Fm-mediated inhibition of EGFR and PVR-induced signalling. Instead, Dock expression increased, and PTP61Fm coexpression further exacerbated the PVR-induced eye overgrowth. These results demonstrate that Dock selectively enhances the PTP61Fm-mediated attenuation of InR signalling and underscores the specificity of PTPs and the importance of adaptor proteins in regulating PTP function in vivo.
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Introduction
Tyrosine phosphorylation is a reversible dynamic process controlled by the opposing activities of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) [1] . PTPs are a large and structurally diverse family of enzymes found in eukaryotes, prokaryotes and plants. Classical tyrosine-specific PTPs are integral to the control of PTK activation and downstream tyrosine phosphorylation-dependent signalling, initiating or setting thresholds for PTK activation and influencing both the amplitude and duration of tyrosine phosphorylation-dependent signalling [1] . Multiple PTPs are involved in the regulation of any given PTK or PTK substrate, acting on distinct, as well as overlapping tyrosine phosphorylation sites [1] . However, such apparent overlapping regulation can occur in a temporally and spatially restricted manner [2] [3] [4] [5] .
The capacity for PTPs to act in a coordinated manner to regulate signalling is exemplified by the activities of two of the most closely related tyrosine-specific PTPs in the human genome, PTP1B (encoded by PTPN1) and TCPTP (encoded by PTPN2) [1] . The catalytic domains of these two phosphatases share a high degree of primary (72% identity, 86% similarity) and tertiary structure similarity [1, 6] . The two phosphatases have virtually identical active sites and have an adjacent phosphotyrosine-binding pocket that allows for the recognition of substrates with tandem phosphorylation sites [7, 8] , such as the Y1162/Y1163 site present in the insulin receptor (InR) b-subunit PTK activation loop, or the corresponding tandem tyrosine phosphorylation site in Janus-activated kinase (JAK) family PTKs [1, 5] .
Despite this similarity, PTP1B and TCPTP are not redundant, but rather function cooperatively to regulate PTK activation and signalling [1, 5] . For example, both phosphatases dephosphorylate the InR Y1162/ Y1163 site in a temporally distinct manner with PTP1B acting early to regulate the intensity of InR activation, and TCPTP controlling the duration of InR signalling [2, 5] . Similarly, PTP1B and TCPTP differentially regulate JAK signalling with PTP1B dephosphorylating JAK-2 and Tyk2 and TCPTP dephosphorylating JAK-1 and JAK-3 [9] [10] [11] . Additionally, PTP1B and TCPTP act cooperatively to regulate JAK/signal transducer and activator of transcription (STAT) signalling [1, 12, 13] , with PTP1B for example dephosphorylating JAK-2 in the cytoplasm [10, 11] and TCPTP dephosphorylating the JAK-2 substrate STAT-3 in the nucleus, to suppress leptin-induced JAK-2/ STAT-3 signalling in the hypothalamus [13] . Although in part, substrate selectivity is conferred by inherent catalytic domain specificity, the distinct subcellular distributions of the phosphatases also influence substrate access [1] .
PTP1B is targeted to the cytoplasmic face of the endoplasmic reticulum (ER) by a noncatalytic hydrophobic C terminus [14] . PTP1B dephosphorylates receptor PTKs, such as the InR, platelet-derived growth factor receptor (PDGFR) and the epidermal growth factor receptor (EGFR) at the cell surface and cell junctions and after receptor PTK endocytosis [1, 3, 4, 15, 16] . PTP1B also dephosphorylates cytosolic PTKs to either suppress or promote PTK signalling [1] . For example, PTP1B dephosphorylates the C-terminal Y527 inhibitory site on Src family kinases (SFKs) to activate SFKs and promote PTK signalling [17, 18] , but dephosphorylates and inactivates JAK PTKs to attenuate cytokine signalling [9] [10] [11] . TCPTP is expressed as two variants with identical catalytic domains, but distinct C termini arising from the alternative splicing of mRNA: a 48 kDa variant (TC48) with a hydrophobic C terminus that is targeted to the ER, like PTP1B, and a 45 kDa variant (TC45) with a shorter hydrophilic C-terminal tail that is targeted to the nucleus by a bipartite nuclear localisation sequence (NLS) [19, 20] . Despite having an apparent exclusive nuclear localisation in resting mammalian cells, TC45 can shuttle between the nucleus and cytoplasm [21, 22] and access substrates such as the InR, JAK-1/3 [2, 9, 23, 24] and SFKs [25] [26] [27] , and nuclear substrates such as STAT-1/3 [13, 28] to regulate growth factorand cytokine-induced signalling. Recent studies suggest that TC45's capacity to dephosphorylate STAT-3 in the nucleus may be controlled by targeting proteins, such as GDX [29] and SIPAR [30] , whereas the dephosphorylation of cytoplasmic substrates, such as c-Src or JAK-1/3, for the repression of TNF-induced MAPK signalling and interleukin (IL)-2-induced STAT-5 signalling may be orchestrated by the adaptor proteins TRAF2 [25] and TRAF3 [31] respectively. Similarly, we have shown previously that the Drosophila SH3/SH2 adaptor protein Dock (Dreadlocks), or its mammalian counterpart Nck, facilitate PTP61F-mediated InR dephosphorylation in flies, or PTP1B-mediated InR dephoshorylation in mammalian cells [32] . However, a direct assessment of the contribution of any given adaptor protein to the regulation of defined PTKbiological processes in vivo by PTPs has not been assessed.
In Drosophila, PTP1B and TCPTP have a single orthologue, PTP61F [33] . Alternative splicing of Ptp61F mRNA gives rise to PTP61Fm, which is targeted to the ER by a hydrophobic C-terminus [33] like PTP1B/TC48 [1] , and PTP61Fn, which lacks the hydrophobic C-terminus and is targeted to the nucleus by a NLS [33] , like TC45 [19] . The PTP61F catalytic domain exhibits 69-72% similarity to that of PTP1B or TCPTP, and also contains the additional phosphotyrosine-binding pocket that allows for the recognition of tandem tyrosine phosphorylated substrates in PTP1B/TCPTP [1] . Indeed, like PTP1B/TCPTP, PTP61F dephosphorylates the Drosophila InR Y1553/ Y1554 PTK activation loop autophosphorylation site to suppress insulin signalling in flies [34] . PTP61F also regulates JAK/STAT (Hopscotch/STAT92E) signalling in flies [34] [35] [36] [37] . For example, we have shown previously that STAT92E Y711 phosphorylation is increased in the ovaries of Ptp61FD mutant flies (null for PTP61Fm and PTP61Fn) contributing to defects in fecundity [34] . The PTP61F-mediated attenuation of JAK/STAT signalling is thought to occur at the level of Hopscotch or STAT92E [36, 37] . It remains unclear if PTP61F can also act directly on Hopscotch and whether the PTP61F ER and nuclear variants coordinately regulate Hopscotch/STAT92E signalling in flies as noted for PTP1B and TCPTP in mammals [1] . Here we have taken advantage of Drosophila as a model organism to explore the in vivo roles of the PTP61F variants in receptor PTK and JAK/STAT signalling and the role of the adaptor Dock in influencing PTP61F function in the regulation of defined receptor PTKs.
Results

PTP61Fn negatively regulates EGFR signalling
We have shown previously that PTP61F and its mammalian orthologues PTP1B and TCPTP dephosphorylate the InR and attenuate InR signalling in vivo [32] . Although PTP1B and TCPTP have been implicated in the regulation of several receptor PTKs, including the EGFR and PDGFR [1] , the role of PTP61F in the regulation of other receptor PTKs in vivo remains unclear. Accordingly, we examined whether PTP61F might regulate Drosophila EGFR signalling. To this end, we made use of the dominant EGFR Ellipse mutant, EGFR ElpB1 (EGFR E3 ). This mutant fly arose from an ethylmethylsulfonic acid mutagenesis screen and was mapped to the endogenous EGFR locus [38] . EGFR ElpB1 has a single amino acid substitution in the EGFR PTK domain that is an activating mutation, and results in a small rough eye phenotype, primarily due to reduced specification of the R8 photoreceptor cell and differentiation defects [39] . During pupal development, excess cells surrounding each photoreceptor cluster are eliminated by apoptosis, thereby resulting in a smaller and disorganised adult eye. To modulate PTP61F expression, we used the ey-GAL4 driver (which is expressed in the developing eye epithelium from the late embryo to late larval stages) to ectopically express either GFP as a control, or the PTP61F nuclear-targeted splice variant PTP61Fn [34] , in the developing eye epithelium. Although expression of Ptp61Fn in a wild-type background showed a small, but significant reduction in eye size, there was no effect on eye patterning in both males (Fig. 1B relative (Fig. 1J , quantified in 1N), consistent with PTP61F knockdown driving endogenous RTK pathways that promote growth.
To reaffirm the role of PTP61F in EGFR signalling, we also tested if PTP61F overexpression or deficiency could modulate the eye overgrowth phenotype associated with the ectopic expression of a constitutively active EGFR transgene (UAS-EGFR ktop ), which contains a extracellular dimerisation domain from the lambda CI protein, and therefore is constitutively dimerised and active [40] . When this activated form of EGFR is expressed via the ey-GAL4 driver throughout development in the proliferating cells of the eye epithelium, additional founder cells are produced leading to more R8 cells and additional photoreceptor clusters, resulting in a larger adult eye (Fig. 2E ). PTP61Fn overexpression robustly suppressed the ey>EGFR ktop overgrown eye phenotype ( Fig. 2F compared with 2E, quantified in 2M). Conversely, reducing PTP61F levels, via heterozygosity of the Ptp61F null allele (Ptp61FD), or using the Ptp61F-RNAi transgene to knockdown PTP61F expression, resulted in the enhancement of the ey>EGFR ktop overgrown eye phenotype (Fig. 2G , H compared with 2E, quantified in 2M). Ptp61F-RNAi expression alone also resulted in an enlarged eye (Fig. 2D) ; however, this was significantly increased when EGFR ktop was coexpressed (Fig. 2H , quantified in 2M). Thus, PTP61F represses the tissue overgrowth effects due to ectopic EGFR activation. Taken together these results identify PTP61F as a negative regulator of EGFR signalling in flies.
PTP61F negatively regulates PVR signalling
We next examined whether PTP61F could modulate signalling through PVR [41] , the Drosophila homologue of the mammalian PDGFR and vascular endothelial growth factor receptor PTKs, both of which are dephosphorylated by PTP1B and TCPTP [16, [42] [43] [44] . To this end we assessed the influence of PTP61Fn overexpression or deficiency on the overgrowth associated with the expression of a ligandindependent activated allele of PVR (UAS-PVR k ) in the Drosophila eye [45] . As expected, overexpression of UAS-PVR k via the ey-GAL4 driver resulted in overgrown adult eyes ( by RNAi-mediated knockdown, not only enhanced the ey>PVR k overgrown eye phenotype (Fig. 2K, 2L compared with 2I, quantified in 2M) but also resulted in overt morphological defects in every instance (arrowheads). These results are consistent with PTP61F being a negative regulator of PVR signalling.
PTP61F negatively regulates EGFR-MAPK signalling
Having established that PTP61F negatively regulates EGFR and PVR signalling, we next explored the pathways by which PTP61F may mediate its effects on receptor PTK signalling. Recent studies have shown that PTP61F negatively regulates mitogen-activated protein kinase (MAPK) signalling in flies [46] . In Drosophila, the MAPK extracellular signal-regulated kinase (ERK) is a well-established downstream effector of EGFR signalling, promoting cellular proliferation, growth and survival [47] . To determine whether the PTP61F-mediated effects on the EGFR ElpB1 rough eye phenotype were accompanied by alterations in Ras-MAPK signalling, we monitored for ERK phosphorylation (p-ERK) in third instar larval eye-antennal epithelial tissue by immunoblot analysis (Fig. 3A) .
Reducing the dosage of PTP61F by using the heterozygous Ptp61FD mutant null allele (Ptp61FD/+) increased p-ERK in wild-type flies and exacerbated the enhanced p-ERK associated with EGFR ElpB1 expression ( Fig. 3A) in keeping with the effects on eye overgrowth. Thus, PTP61F negatively regulates EGFR signalling and the eye overgrowth at least in part by repressing EGFR-Ras-MAPK signalling.
PTP61F negatively regulates PVR-MAPK signalling
It is well established that PVR signals via the MAPKs ERK and c-Jun N-terminal kinase (JNK) [41, 45, 48] . We therefore examined the influence of PTP61F on PVRinduced ERK and JNK signalling. First, we used the ey-FLP-out system to express activated PVR k or PVR tissue and assessed p-ERK status by immunoblotting.
As with EGFR ElpB1 signalling, Ptp61F knockdown resulted in increased ERK phosphorylation and activation (Fig. 3B ). Next we examined whether PTP61F regulates PVR-induced Rac-JNK signalling. We used the equatorial-GAL4 (Eq1-GAL4, termed eq> henceforth) driver, which is expressed in a patch of cells in the centre of the developing eye epithelia [49] , to drive expression of PVR
RNAi and stained for the JNK reporter, metalloproteinase 1 (MMP1) [50] (Fig. 4) . In the Eq patch (marked by green fluorescent protein, GFP), MMP1 was not upregulated by Ptp61F knockdown relative to the control ( Fig. 4B  compared with 3A) . PVR k expression resulted in the upregulation of MMP1 (Fig. 4C) , which was enhanced by knocking down Ptp61F ( Fig. 4D compared with 4C) . Interestingly, PTP61F knockdown alone or with PVR k also resulted in some noncell autonomous upregulation of MMP1 adjacent to the Eq patch ( Fig. 4B,D) . This is consistent with a 'supercompetitor' phenotype being conferred by PTP61F deficiency leading to increased JNK signalling and cell death in surrounding wild-type cells [51] . The growth of the Eq patch in the eye epithelial tissue was also enhanced by PVR k expression, although Ptp61F knockdown did not appear to noticeably enhance this overgrowth ( Fig. 4B compared with 4A, and see Fig. 6E for quantification of Eq domain growth). However, in the third instar larval wing epithelial tissue, where the eq> driver is also expressed, PTP61F deficiency resulted in robust enhancement of PVR k -induced tissue overgrowth with overt perturbations in cellular morphology (Fig. 5B compared to 5A ). Taken together, these results are consistent with PTP61F negatively regulating PVR-driven tissue growth and inhibiting MAPK signalling.
PTP61F negatively regulates PVR -but not EGFRinduced STAT signalling
The morphological alterations associated with PVR overexpression and PTP61F depletion are reminiscent of defects in tissue architecture associated with STAT92E hyperactivation during Drosophila eye development [52, 53] . Given that STAT92E can serve as PTP61F substrate [34] [35] [36] [37] , we next examined whether PTP61F deficiency might enhance PVR-induced STAT92E signalling using a 10XStat-GFP (Stat-GFP) reporter for STAT92E transcriptional activity [54] . We used the eq> driver (marked by UAS-RFP expression) to express PVR
RNAi in the Drosophila developing eye and monitored GFP fluorescence as a read-out of STAT92E activity (Fig. 6 ). PTP61F knockdown alone had no overt effect on Stat-GFP reporter expression (Fig. 6A versus 6B, quantified in 6F). PVR k expression was associated with an expansion of the Eq domain ( Fig. 6C , quantified in 6E) and modest increases in STAT92E activity as assessed by GFP expression (Fig. 6A,C,F) . Strikingly, Ptp61F knockdown in PVR k -expressing tissue resulted in robust increases in Stat-GFP reporter expression (Fig. 6D , quantified in 6F). By contrast, PTP61F-deficiency did not alter STAT92E activity in the context of EGFR ktop expression (data not shown), consistent with the effects being specific to the PVR receptor PTK. As STAT92E hyperactivation elicits both cell autonomous and noncell autonomous effects in the developing Drosophila eye, driving tissue overgrowth [55, 56] , ectopic organiser formation [57] and perturbing specification and omnatidial polarity [53, 58] , it is likely that the heightened JAK/STAT signalling contributes to the tissue overgrowth and the morphological defects associated with PTP61F-deficiency and activated PVR.
PTP61Fm and PTP61Fn differentially regulate Hopscotch and STAT92E
The PTP61F orthologues, PTP1B and TCPTP, dephosphorylate JAK family PTKs and STATs to coordinately regulate JAK/STAT signalling [1] . Both PTP1B and TCPTP dephosphorylate and inactivate JAK PTKs [9] [10] [11] , whereas TCPTP dephosphorylates STAT family members, such as STAT-3, in the nucleus [13, 28] . Given the influence of PTP61F deficiency on PVR-induced STAT92E signalling, we assessed the influence of the endoplasmic reticulum (ER)-versus nuclear-targeted variants of PTP61F on Hopscotch and STAT92E signalling respectively. To this end, we coexpressed in Drosophila Schneider II (Fig. 7A) . Moreover, the PTP61Fm-C237S 'substrate-trapping' mutant, but not the PTP61Fn-C237S mutant, enhanced Hop TumÀ1 tyrosine phosphorylation (Fig. 7A ), in keeping with Hop TumÀ1 serving as a substrate of PTP61Fm, but not PTP61Fn. The ability of the PTP61Fm 'substrate-trapping' mutant to form an enzyme-substrate complex with tyrosine phosphorylated Hop 
The Eq expression domain is outlined by dotted lines and indicated by the arrows. MMP1 is upregulated slightly in PVR k expressing tissue and more robustly increased upon PTP61F knockdown. PTP61F knockdown alone resulted in some increased MMP1 expression adjacent to the Eq expression domain, consistent with PTP61F depletion resulting in supercompetitor cell behaviour.
PTP 'substrate-trapping' mutant, PTP61Fm-D203A (Fig. 7B) (Fig. 8) . We found that wildtype PTP61Fn repressed p-STAT92E, whereas the PTP61Fn-C237S
'substrate-trapping' significantly enhanced p-STAT92E (Fig. 7C) . As PTP61Fn or PTP61Fn-C237S did not overtly influence Hop TumÀ1 phosphorylation (Fig. 7A) , these results are consistent with the formation of a stable PTP active site-dependent complex between p-STAT92E and PTP61Fn-C237S. Finally, we found that the specific knockdown of PTP61Fn in S2 cells enhanced STAT92E tyrosine phosphorylation induced by the secreted ligand Unpaired (Upd), which acts via the Domeless receptor to signal to Hopscotch and STAT92E (Fig. 7D) . Taken together, these results are consistent with both PTP61Fm and PTP61Fn contributing to the suppression of JAK/STAT signalling through the dephosphorylation of Hopscotch and STAT92E respectively.
Eyeless-mediated PTP61Fm expression represses EGFR and PVR but not InR signalling
Given the differential regulation of JAK/STAT signalling by PTP61Fm and PTP61Fn, we also examined the influence of PTP61Fm on the EGFR-versus PVR-induced Drosophila eye overgrowth. Previously, we compared the effects of PTP61Fm versus PTP61Fn on InR-mediated eye overgrowth using the GMR-GAL4 driver, which is expressed in the posterior differentiating cells of the developing eye during third instar larval development [32, 34] . GMR-InR results in a deformed rough eye phenotype due to defects in cell cycle exit and patterning; overexpression of Ptp61Fn corrected this phenotype, whereas Ptp61Fm overexpression only moderately improved the phenotype despite being expressed at higher levels than Ptp61Fn [32, 34] . Here, to assess the effects of PTP61Fm versus PTP61Fn on RTK signalling, we used the ey> driver, which is a weaker driver expressed throughout the developing eye epithelium from embryonic development. ey>InR results in hyperplasia without overt effects on differentiation ( Fig. 9B compared with the wild-type control, 9A). We found that Ptp61Fn robustly suppressed the ey>InR overgrown eye phenotype (Fig. 9C , quantified in Fig. 9G ) but Ptp61Fm did not (Fig. 9D , quantified in 9G), consistent with the differential effects on InR signalling by the PTP61F variants observed previously [32, 34] . By contrast, we found that Ptp61Fm was just as effective as Ptp61Fn in repressing the eye overgrowth associated with EGFR ktop or PVR k overexpression (Figs. 2F compared with 10C, and 2J compared with 10G). Therefore, PTP61Fm and PTP61Fn differentially contribute to the regulation of receptor PTKs.
Dock is required for the PTP61Fm repression of InR but not EGFR or PVR signalling
We have shown previously that PTP61Fm requires the adaptor protein Dock to effectively repress InR signalling [32] . Dock, or it mammalian counterpart Nck, forms stable complexes with PTP61F/PTP1B and the InR to facilitate receptor dephosphorylation and inactivation. We have shown that Dock coexpression, using the GMR-GAL4 driver, enhances the Ptp61Fm-mediated repression of the GMR>InR phenotype [32] . Accordingly, we next determined whether the effects of Ptp61Fm on the ey>InR versus ey>EGFR ktop and ey>PVR k phenotypes may be ascribed to a differential reliance on Dock. Although ey>Ptp61Fm or RNAi , (C) eq-GAL4 UAS-RFP Stat-GFP + UAS-PVR k , (D) eq-GAL4 + UAS-RFP + Stat92E-
RNAi . The Eq expression domain is outlined with dotted lines and indicated with arrows. (E) Quantification (mean AE SEM) of Eq domain area relative to the total eye epithelial area for the genotypes indicted. The Eq domain area was increased for eq>PVR k and eq>PVR k Ptp61F RNAi relative to the control (**P < 0.01). There was no significant change in the area between eq>PVR k and eq>PVR k Ptp61F
RNAi . (F) Quantification of Stat-GFP pixel intensity in the Eq domain relative to the surrounding wild-type tissue of the same area, and normalised to the eq>RFP control for the genotypes indicated. Stat-GFP was increased per unit area in eq>PVR k Ptp61F
RNAi relative to the control (*P < 0.05). There was no significant change in Stat-GFP levels between eq>RFP and eq>Ptp61F RNAi or eq>PVR k .
ey>dock had no effect on the ey>InR phenotype ( Fig. 9D and 9E , compared with 9B, quantified in 9G), the coexpression of dock together with Ptp61Fm repressed the eye overgrowth as effectively as Ptp61Fn (Fig. 9F, compared with Fig. 9C , quantified in 9G). By contrast, the overgrown eye phenotype of ey>E-GFR ktop was attenuated by Ptp61Fm in the absence of dock overexpression ( Fig. 10C compared with 10A , B, quantified in 10J). Dock overexpression alone had no effect and did not enhance the effects of Ptp61Fm on the ey>EGFR ktop overgrown eye phenotype (Fig. 10D ,E compared with 10A-C, quantified in 10J). Similarly, dock overexpression did not enhance the ability of Ptp61Fm to suppress the overgrown eye phenotype of ey>PVR k flies ( Fig. 10G compared 
Discussion
The role of adaptor proteins in influencing the spatial and temporal control of signalling is widely appreciated [59] but their influence on PTP function is not well understood. Although PTPs exhibit inherent catalytic domain substrate specificity [1] , as highlighted for example by catalytic domain swapping experiments between the highly conserved tyrosine phosphatases PTP1B and TCPTP [21] , or SHP-1 and SHP-2 [60] , different adaptors have been shown to enhance the PTP-mediated dephosphorylation of PTKs and their target substrates [25, [29] [30] [31] [32] . It remains unclear if any given adaptor can confer specificity for select substrates and biological pathways. Here we have used Drosophila as a model organism to demonstrate that the adaptor protein Dock is required for the PTP61Fm-mediated repression of InR, but importantly, not EGFR-or PVR-induced Drosophila eye overgrowth (Fig. 11) . These results highlight the capacity of adaptor proteins to selectively influence PTK-mediated biological processes through the targeted recruitment of PTPs. In contrast to the requirement for Dock in the PTP61Fm-mediated repression of InR signalling, the nuclear-targeted PTP61Fn repressed the InR-induced eye overgrowth in the absence of Dock. Similarly, PTP61Fn also effectively suppressed EGFR-and PVR-induced hypertrophy in the absence of Dock. Genetic analyses of Drosophila, InR, EGFR and PVR have contributed significantly to our understanding of the corresponding receptor PTK pathways in mammals and have highlighted the high degree of pathway conservation between mammals and flies [61] . We have established previously that the mammalian PTP61Fn orthologue, TC45, shuttles in and out of the nucleus and is targeted to the cell periphery where it desphosphorylates the EGFR family member ErbB1 to repress phosphatidylinosital 3-kinase (PI3K)-mediated AKT and JNK signalling [21, 22, 62] . Similarly, TC45 exhibits specificity for PDGFR tyrosine phosphorylation sites to selectively regulate phospholipase Cc1 signalling [44] . Ptp61Fn overexpression in the Drosophila eye represses InR Y1553/Y1554 phosphorylation and the InR-induced hypertrophy, but has no effect on overgrowth induced by PI3K overexpression [32] , in keeping with PTP61Fn acting upstream of PI3K to dephosphorylate the InR. In addition, recent studies have shown that PVR can serve as a direct substrate for PTP61F [63] . Although in this study we have not specifically examined EGFR or PVR tyrosine phosphorylation after Ptp61Fn overexpression or deletion, we propose that PTP61Fn represses the eye overgrowth through the dephosphorylation and inactivation of the respective receptor PTKs at the plasma membrane and/or cytoplasm. In keeping with this, we found that downstream MAPK signalling was attenuated by the Ptp61Fn variant. However, we cannot exclude the possibility that PTP61Fn may in part elicit its effects by acting downstream of receptor PTKs, or indeed through direct effects on the Ras/MAPK pathway, as recent studies suggest that PTP61F may act on MAPK itself [46] . Downstream PTKs that may be dephosphorylated by PTP61F include the Abl PTK, with previous studies suggesting that Abl may mediate EGFR signalling in flies, and that Abl can serve as a direct substrate of PTP61F to regulate actin organisation [46, 64] . Yet another potential downstream tyrosine phosphorylation-dependent pathway by which PTP61Fn may mediate its effects on receptor PTK signalling is the JAK/STAT pathway. Indeed, we found that JAK/STAT signalling, as assessed by monitoring STAT92E transcriptional activity, was elevated in the absence of PTP61F, in keeping with previous studies showing that Ptp61F deficiency is associated with enhanced STAT92E Y711 phosphorylation [34] [35] [36] [37] . However, this only occurred when PVR k was overexpressed. Ptp61F deficiency did not enhance EGFR ktopinduced STAT92E transcriptional activity, pointing towards context-dependent regulation of the JAK/ STAT pathway. Importantly, we also found that the PTP61F variants differentially contributed to the regulation of JAK/STAT pathway, at least in S2 cells, with PTP61Fm acting on Hopscotch and PTP61Fn acting on STAT92E. These results suggest that the ER localisation of PTP61Fm may be essential for the dephosphorylation of Hopscotch, whereas PTP61Fn may dephosphorylate STAT92E in the nucleus, as noted previously for TC45 and STAT3 [13] . Together, these results provide evidence for PTPs acting in a contextdependent-manner to regulate PTK signalling and reinforce the importance of localisation in dictating substrate selectivity. Despite PTP61Fm being reliant on Dock for the repression of InR-induced eye overgrowth, PTP61Fm was capable of effectively repressing the EGFR or PVR-induced eye overgrowth without Dock. We have argued previously that the differential effects of PTP61Fm versus PTP61Fn on InR signalling may be ascribed to their differential localisation with PTP61Fn having unfettered access by virtue of its ability to shuttle between the nucleus and cytoplasm, and PTP61Fm being restricted because of its ER localisation [32] . We were able to demonstrate that PTP61Fm, Dock and InR formed a ligand-dependent complex and that the PTP61F-mediated interaction with Dock was required for InR dephosphorylation in vitro and in vivo [32] . Accordingly, we reasoned that Dock was required to recruit the ER-restricted PTP61Fm to the InR at the plasma membrane. Dock interacts with PTP61F via the Dock SH3 domains and the PTP61F noncatalytic C terminus that contains five proline-rich SH3-interaction (PxxP) motifs [65, 66] . Dock forms a complex with the InR and PTP61Fm and facilitates the PTP61Fm-mediated dephosphorylation of the InR [32] . InR contains a 400-amino-acid C-terminal extension that is not found in mammalian IR and contains PxxP motifs that can interact with the Dock SH3 domain in a yeast two-hybrid screen [66] [67] [68] . Other studies point towards InR tyrosine phosphorylation and the Dock SH2 phosphotyrosine-binding domain being important for the interaction, whereas genetic studies point towards a redundancy between the Dock SH2 and SH3 domains during the process of InR-mediated R-cell axon guidance [32, 34, 66, 69] . Therefore, Dock's specific contributions to InR regulation by PTP61Fm may be attributed to sequence-specific interactions between the Dock SH2/SH3 domains and the InR. However, this does not explain how PTP61Fm can function independently of Dock in the regulation of EGFR and PVR signalling. One possible reason may be that PTP61Fm also acts downstream of the EGFR and PVR receptor PTKs. However, another possibility is that the differential requirement for Dock may relate to differences in receptor PTK trafficking. Although this has not been studied extensively in flies, in mammalian cells the InR undergoes rapid recycling to the plasma membrane [70] , whereas EGF-bound EGFR (ErbB1) undergoes endosomal sorting and lysosomal degradation [71, 72] . Similarly, the PDGFR is reported not to recycle [73] . Interestingly, TCPTP deficiency induces recycling of PDGFR b homodimers and ab heterodimers [74] . Therefore, one possibility is that PTP61Fm may have access to the EGFR and PVR receptor PTKs after endocytosis, where Dock or other adaptor proteins may not be necessary for their dephosphorylation. Although PTP61F expression repressed the PVRinduced eye hypertrophy, the expression of Dock with PVR exacerbated tissue growth. Paradoxically, the coexpression of PTP61F with PVR and Dock further exacerbated the Dock-induced overgrowth and resulted in morphological defects. Precisely how PTP61F might cooperate with Dock to worsen the Dock-mediated PVR-dependent overgrowth remains unclear. It is possible that the PTP61F-mediated repression of PVR-, but promotion of the Dockinduced overgrowth may be elicited via independent pathways. Dock and PTP61F may have opposing roles in actin polymerisation [63, 64, 75, 76] . Perhaps in the activated PVR background, the coexpression of PTP61Fm with Dock, which itself is tyrosine phosphorylated by Src42A and dephosphorylated by PTP61F [77] , perturbs actin polymerisation to influence tissue growth [78] .
In summary, our studies provide insight into potential approaches for selectively manipulating receptor PTK signalling in biology and disease. PTP1B negatively regulates InR signalling in muscle and liver and PTP1B knockout mice have improved glucose metabolism [79] [80] [81] [82] [83] . Moreover, increased PTP1B expression and/or activity may contribute to the development of muscle insulin resistance in rodents and humans [84] [85] [86] [87] [88] [89] . The inhibition of PTP1B may provide an important means by which to selectively promote insulin sensitivity and alleviate insulin resistance in type 2 diabetes. We have shown previously that the mammalian Dock homologue, Nck, similarly facilitates InR dephosphorylation [32] . Moreover, Nck deletion in high-fat diet-fed obese mice improves glucose tolerance and insulin sensitivity [90] , whereas Nck-deficiency in hepatocytes promotes insulin-induced PI3K/AKT signalling [91] . Our studies suggest that the specific targeting of PTP61F/PTP1B interactions with Dock/ Nck might allow for the selective enhancement of InR signalling without affecting other PTKs and provide an alternative means by which to enhance insulin sensitivity in type 2 diabetes.
Materials and methods
Fly stocks
Fly stocks used in this study were: UAS-Ptp61F n , UAS- , and ey-GAL4, UAS-GFP and UAS-RFP (Bloomington stock centre). The ey-FLP-out stock used was, ey-FLP;; act>CD2>GAL4,UAS-GFP generated from component stocks from the Bloomington stock centre. All flies were raised on a standard semolina agar food at 25°C, or 29°C when using the Ptp61F-RNAi line. At least 50 progeny of the relevant genotype were analysed per cross and images were taken from at least five representative fly eyes per genotype for analysis.
Immunofluorescence microscopy
Third instar larval eye-antennal or wing discs were dissected in phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde for 30 min, washed in PBS + 0.1 or 0.3% Triton X-100 (PBT), and blocked in PBT + 1% BSA. To stain for MMP1, the mouse monoclonal anti-MMP1 antibody was used at 1 : 20 (Developmental Studies Hybridoma Bank, 5H7B11, 3B8D12 & 3A6B4). The secondary antibody, anti-mouse Alexa 568 was used. DNA was stained with 2-(4-amidinophenyl)-1H-indole-6-carboxamidine (DAPI, 1 lM). F-actin was detected using phalloidintetramethylrhodamine isothiocyanate-rhodamine (Sigma, 0.3 mM). Labelled samples were mounted in 80% glycerol and analysed by confocal microscopy (LEICA TCS SP5, Zeiss Confocal LSM 780 PicoQuant FLIM).
Imaging adult fly eyes
Adult male eyes were imaged using a light dissection microscope or a Scitec Infinity1 camera, or a fluorescence dissection microscope and a CCD black-white camera. Male flies were collected after anaesthetising with CO 2 and stored at À20°C until ready for imaging. Flies were mounted on a device that enabled consistent positioning of each fly eye at the same distance from the microscope. Images from at least five adult male eyes were taken per genotype using identical microscopy settings.
Cell culture and transfections
Drosophila S2 cells were maintained in 1X Schneider medium (Invitrogen, ThermoFisher Scientific, Waltham, MA, USA) plus 10% (v/v) FBS at 24°C. Transient transfections were performed with Lipofectamine 2000 (Invitrogen) as described previously [32, 34] . For RNA interference (RNAi)-mediated knockdown in S2 cells, double-stranded RNAs (dsRNAs) corresponding to the Ptp61Fn gene were added to S2 cells cultured in serum-free medium and processed as described previously [32, 34] .
Generation of p-STAT92E antibodies
The synthetic peptide C 703 VLDPVTGpYVKST 715 -NH 2 corresponding to Y711 phosphorylated STAT92E from Drosophila melanogaster was conjugated to keyhole limpet haemocyanin (KLH) and New Zealand White rabbits injected with 200 lg conjugate in 50% (v/v) Freund's incomplete adjuvant biweekly. Serum was collected 10 days after the sixth boost and frozen at À80°C.
Immunoblotting
Drosophila eye-antennal discs (~20) were homogenised in 100 mM M Tris/HCl pH 6.8, 2% (w/v) SDS, 5 mM EDTA, 5 mM DTT, complete protease inhibitor cocktail (Roche), 1 mM Na 3 (VO) 4 and 5 mM NaF and processed for immunoblotting with a-phospho-ERK (Sigma, Saint-Louis, MO, USA), a-ERK (Cell Signaling, Danvers, MA, USA) and a-tubulin (Sigma). S2 cells were processed for immunoprecipitation with anti-Myc (9E10; Abcam, Cambridge, UK) and/or immunoblotting as described previously [32, 34] with antibodies to phosphotyrosine (4G10; Merck Millipore, Billerica, MA, USA), Myc (9E10), HA (12CA5; Abcam), Y704 phosphorylated STAT92E and STAT92E (Santa Cruz, Biotechnology, Santa Cruz, CA, USA).
Statistical analysis
Adult eye areas were measured (from n > 5 flies per genotype) using the magnetic lasso tool to highlight the eye perimeter and the Measurement plugin of Adobe Photoshop CS5.1 or CC Premium. The data were plotted using Microsoft Excel or Graphpad Prism, and the data were analysed using the Student's t-test with significance set at P < 0.05.
Relative Stat-GFP staining within eye epithelium was determined from images taken at the same confocal settings. Average pixel intensity of Stat-GFP was measured using the measurement log tool from Photoshop 5.1 in the Eq domain (marked by RFP) in the eye epithelium. Average pixel intensity was measured in the Eq domain relative to the adjacent wild-type tissue of the same area (n~10 for each sample) and data were normalised to the eq>RFP control. Data were compared and plotted using Microsoft Excel and the data were analysed using the Student's t-test with significance set at P < 0.05.
Relative Eq domain area (marked by RFP) was measured in each sample relative to the total eye disc area using the measurement log tool from Photoshop 5.1. Data were compared and plotted as a percentage of total eye size for each genotype using Microsoft Excel and the data were analysed using the Student's t-test with significance was set at P < 0.05.
